Literature DB >> 2887194

Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma.

L Ceccherini-Nelli, V De Re, A Viel, G Molaro, L Zilli, C Clemente, M Boiocchi.   

Abstract

It is not yet clear whether some polymorphic variants of the Ha-ras-1 gene confer genetic predisposition to cancer. However, recent data on myelodysplasia and lung cancer are controversial. To clarify this point, 62 colorectal adenocarcinoma patients were examined for the Ha-ras-1 gene restriction fragment length polymorphism and results were compared with those of 108 healthy blood donors. No Ha-ras-1 polymorphic variants specifically associated with the cancer patients were detected. However, a specific genotype was significantly more frequent in the healthy donors than in the cancer patients (16% versus 5%), suggesting an interaction between the two alleles of the gene.

Entities:  

Mesh:

Year:  1987        PMID: 2887194      PMCID: PMC2001679          DOI: 10.1038/bjc.1987.143

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

2.  Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.

Authors:  J B Gibbs; I S Sigal; M Poe; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Restricted expression of integrated primate type-C virus (gibbon ape leukemia virus-simian sarcoma virus) proviral DNA in nonproductively infected human B lymphoblasts.

Authors:  L C Nelli; R Dalla-Favera; P D Markham; F W Ruscetti; F Wong-Staal; R C Gallo; M S Reitz
Journal:  Virology       Date:  1982-02       Impact factor: 3.616

4.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.

Authors:  D J Capon; E Y Chen; A D Levinson; P H Seeburg; D V Goeddel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

5.  Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.

Authors:  J Fujita; O Yoshida; Y Yuasa; J S Rhim; M Hatanaka; S A Aaronson
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

6.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

7.  The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.

Authors:  R W Sweet; S Yokoyama; T Kamata; J R Feramisco; M Rosenberg; M Gross
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

8.  Expression of cellular oncogenes in human malignancies.

Authors:  D J Slamon; J B deKernion; I M Verma; M J Cline
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

9.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.

Authors:  E H Chang; M E Furth; E M Scolnick; D R Lowy
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

10.  Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum.

Authors:  D A Spandidos; I B Kerr
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

View more
  7 in total

1.  Anti-vimentin antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.

Authors:  A Carbone; A Gloghini; R Volpe; M Boiocchi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Allele-specific deletion in exon I of the HRAS1 gene.

Authors:  A Kasperczyk; B A Mermer; D R Parkinson; J A Lonergan; T G Krontiris
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

3.  TaqI polymorphism within the c-Ha-ras-1 VTR is associated with melanoma.

Authors:  N K Hayward; D J Nancarrow; P G Parsons; C Kidson; K A Ellem
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

4.  Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.

Authors:  R Klingel; P Mittelstaedt; W G Dippold; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

5.  Population genetics of the HRAS1 minisatellite locus.

Authors:  B Devlin; T Krontiris; N Risch
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

6.  Immunoglobulin and T cell receptor gene rearrangements and in situ immunophenotyping in lymphoproliferative disorders.

Authors:  A Carbone; V De Re; A Gloghini; R Volpe; M Tavian; U Tirelli; S Monfardini; M Boiocchi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Restriction fragment length polymorphism of the L-myc gene in oral cancer patients.

Authors:  D Saranath; R G Panchal; R Nair; A R Mehta; V Sanghavi; M G Deo
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.